Trial · NCT01195636
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Intervention (3 Weeks) | STARTED | XPF-002 First, Then Placebo | 35 | |
| First Intervention (3 Weeks) | STARTED | Placebo First, Then XPF-002 | 35 | |
| First Intervention (3 Weeks) | Received at Least 1 Dose of Drug | XPF-002 First, Then Placebo | 33 | |
| First Intervention (3 Weeks) | Received at Least 1 Dose of Drug | Placebo First, Then XPF-002 | 35 | |
| First Intervention (3 Weeks) | COMPLETED | XPF-002 First, Then Placebo | 30 | |
| First Intervention (3 Weeks) | COMPLETED | Placebo First, Then XPF-002 | 32 | |
| First Intervention (3 Weeks) | NOT COMPLETED | XPF-002 First, Then Placebo | 5 | |
| First Intervention (3 Weeks) | NOT COMPLETED | Placebo First, Then XPF-002 | 3 | |
| Washout Period (2 Weeks) | STARTED | XPF-002 First, Then Placebo | 30 | |
| Washout Period (2 Weeks) | STARTED | Placebo First, Then XPF-002 | 32 | |
| Washout Period (2 Weeks) | COMPLETED | XPF-002 First, Then Placebo | 28 | |
| Washout Period (2 Weeks) | COMPLETED | Placebo First, Then XPF-002 | 29 | |
| Washout Period (2 Weeks) | NOT COMPLETED | XPF-002 First, Then Placebo | 2 | |
| Washout Period (2 Weeks) | NOT COMPLETED | Placebo First, Then XPF-002 | 3 | |
| Second Intervention (3 Weeks) | STARTED | XPF-002 First, Then Placebo | 28 | |
| Second Intervention (3 Weeks) | STARTED | Placebo First, Then XPF-002 | 29 | |
| Second Intervention (3 Weeks) | COMPLETED | XPF-002 First, Then Placebo | 27 | |
| Second Intervention (3 Weeks) | COMPLETED | Placebo First, Then XPF-002 | 27 | |
| Second Intervention (3 Weeks) | NOT COMPLETED | XPF-002 First, Then Placebo | 1 | |
| Second Intervention (3 Weeks) | NOT COMPLETED | Placebo First, Then XPF-002 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01195636/flow